mk 0663 has been researched along with Musculoskeletal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldington, S; Beasley, R; Shirtcliffe, P; Weatherall, M | 1 |
| Derry, S; McQuay, HJ; Moore, RA | 1 |
2 review(s) available for mk 0663 and Musculoskeletal Diseases
| Article | Year |
|---|---|
Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy.
Topics: Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Humans; Musculoskeletal Diseases; Pyridines; Randomized Controlled Trials as Topic; Risk; Sulfones; Thromboembolism | 2005 |
Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports.
Topics: Arthritis, Rheumatoid; Drug Administration Schedule; Etoricoxib; Humans; Musculoskeletal Diseases; Pain; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2008 |